Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes

Author： Xicoy Blanca   Jiménez María-José   García Olga   Bargay Joan   Martínez-Robles Violeta   Brunet Salut   Arilla María-Jesús   Pérez de Oteyza Jaime   Andreu Rafael   Casaño Francisco-Javier   Cervero Carlos-Javier   Bailén Alicia   Díez María   González Bernardo   Vicente Ana-Isabel   Pedro Carme   Bernal Teresa   Luño Elisa   Cedena María-Teresa   Palomera Luis   Simiele Adriana   Calvo José-Manuel   Marco Víctor   Gómez Eduardo   Gómez Marta   Gallardo David   Muñoz Juan   de Paz Raquel   Grau Javier   Ribera Josep-Maria   Benlloch Luis-Enrique   Sanz Guillermo  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1300-1303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment Strategies in Myelodysplastic Syndromes

By Atallah Ehab   Garcia-Manero Guillermo  

Cancer Investigation, Vol. 26, Iss. 2, 2008-02 ,pp. : 208-216

Informa Healthcare

Access to resources Recommend Favorite

Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

By Prebet Thomas   Charbonnier Aude   Gelsi-Boyer Véronique   Mozziconacci Marie Joelle   Blaise Didier   Vey Norbert  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1538-1540

Informa Healthcare

Access to resources Recommend Favorite

Azacitidine in Lower‐Risk Myelodysplastic Syndromes: A Meta‐Analysis of Data from Prospective Studies

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 159-170

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older

By Shukuya Takehito   Takahashi Toshiaki   Harada Hideyuki   Ono Akira   Akamatsu Hiroaki   Taira Tetsuhiko   Kenmotsu Hirotsugu   Naito Tateaki   Murakami Haruyasu   Endo Masahiro   Takahashi Kazuhisa   Yamamoto Nobuyuki  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 176-183

Oxford University Press

Access to resources Recommend Favorite

Considerable improvement in survival for patients aged 60-84 years with high grade malignant gliomas - Data from the Swedish Brain Tumour Population-based Registry

By Asklund Thomas  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 1041-1043

Informa Healthcare

Access to resources Recommend Favorite